Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis and recurrence.
| Last: | $0.85 |
|---|---|
| Change Percent: | -31.76% |
| Open: | $1.12 |
| Close: | $0.85 |
| High: | $1.47 |
| Low: | $0.7343 |
| Volume: | 285,054 |
| Last Trade Date Time: | 12/23/2024 03:00:00 am |
| Market Cap: | $2,082,500 |
|---|---|
| Float: | 1,964,900 |
| Insiders Ownership: | N/A |
| Institutions: | 5 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.anpacbio.com |
| Country: | CN |
| City: | New York |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Fresh2 Group Limited (NASDAQ: FRES).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.